Close
Nordic 9Nordic 9

EnginZyme (private company)

Sweden enginzyme.com
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth services
Business model:B2B

EnginZyme aims to make biocatalysis the first choice for chemical process designers worldwide. Biocatalysis offers a sustainable alternative to chemical catalysis in industry. Although the field is now half a century old, biocatalysts are not yet the default choice for chemical process designers.

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 34.76M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to EnginZyme

Name Criteria
Germany Atai Life Sciences
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands Leyden Labs
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Ochre Bio
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom bit.bio
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Synthace
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Italy Kither Biotech
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Epitopea
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Top